Challenges for corporate ethics in marketing genetic tests
Journal of Business Ethics 77 (1):33 - 44 (2008)
| Abstract | Public discussions of ethical issues related to the biotechnology industry tend to treat “biotechnology” as a single, undifferentiated technology. Similarly, the pros and cons associated with this entire sector tend to get lumped together, such that individuals and groups often situate themselves as either “pro-” or “anti-” biotechnology as a whole. But different biotechnologies and their particular application context pose very different challenges for ethical corporate decision-making. Even within a single product category, different specialty products can pose strikingly different ethical challenges. In this paper, we focus on the single over-arching category of “genetic testing” and compare tests for disease susceptibility and drug response. We highlight the diversity of ethical challenges – grouped under the broad categories of “truth in advertising” and “protecting intellectual property” – raised by the commercialization and marketing of these technologies. By examining social and technical differences between genetic tests, and the associated corporate ethics challenges posed by their commercialization, our intent is to contribute to the nascent business ethics literature examining issues raised by the development and marketing of genetic tests. | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,653 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesFelix Thiele (2003). Genetic Tests in the Insurance System: Criteria for a Moral Evaluation. Poiesis and Praxis 1 (3):185-195.
Laura Radulian (2005). Marketing of Harmful Products. International Corporate Responsibility Series 2:329-357.
Margaret L. Eaton (2004). Ethics and the Business of Bioscience. Stanford Business Books.
Bert van De Ven (2008). An Ethical Framework for the Marketing of Corporate Social Responsibility. Journal of Business Ethics 82 (2):339 - 352.
Suli Sui & Margaret Sleeboom-Faulkner (2007). Commercial Genetic Testing in Mainland China: Social, Financial and Ethical Issues. Journal of Bioethical Inquiry 4 (3).
Barabara Biesecker (1998). Future Directions in Genetic Counseling: Practical and Ethical Considerations. Kennedy Institute of Ethics Journal 8 (2):145-160.
George G. Brenkert (2008). Marketing Ethics. Blackwell Pub..
Cheryl Berg & Kelly Fryer-Edwards (2008). The Ethical Challenges of Direct-to-Consumer Genetic Testing. Journal of Business Ethics 77 (1):17 - 31.
John M. T. Balmer, Shaun M. Powell & Stephen A. Greyser (2011). Explicating Ethical Corporate Marketing. Insights From the BP Deepwater Horizon Catastrophe: The Ethical Brand That Exploded and Then Imploded. Journal of Business Ethics 102 (1):1-14.
Ludvig Beckman (2004). Are Genetic Self-Tests Dangerous? Assessing the Commercialization of Genetic Testing in Terms of Personal Autonomy. Theoretical Medicine and Bioethics 25 (5-6).
Analytics
Monthly downloads
Sorry, there are not enough data points to plot this chart.
|
Added to index2009-01-28Total downloads4 ( #178,473 of 548,984 )Recent downloads (6 months)1 ( #63,327 of 548,984 )How can I increase my downloads? |
My notes
Discussion
